Glaxo Gets Boost From Merck Drug Deal

GlaxoSmithKline boosted its over-the-counter medicines business on Monday by signing a deal to sell a non-prescription version of Merck & Co.’s cholesterol-lowering drug Mevacor.
Yahoo! News